PURE Bioscience, Inc. Financial Ratios — PURE Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	07/31/2010	07/31/2011	07/31/2012	07/31/2013	07/31/2014	07/31/2015	07/31/2016	07/31/2017	07/31/2018	07/31/2019	07/31/2020	07/31/2021	07/31/2022	07/31/2023	07/31/2024

Return on Common Equity (%)	-108.5	-173.91	-353.83	- -	- -	-635.58	-388.09	-198.42	-578.92	-530.47	0.13	-56.95	-96.41	-189.48	- -
Return on Assets (%)	-99.11	-149.87	-185.09	-235.31	-563.63	-297.93	-265.56	-109.96	-232.42	-290.84	0.1	-43.65	-79.46	-125.57	-253.5
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.3	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.13	- -	- -	- -	- -
Gross Margin (%)	67.61	71.77	67.49	31.1	37.45	60.91	65.79	58.49	56.99	61.86	58.13	52.84	53.97	51.73	58.69
EBITDA Margin (%)	-442.09	-1,701.72	-1,030.67	-789.88	-1,618.18	-1,019.75	-530.49	-313.05	-380.89	-280.15	2.83	-54.47	-170.37	-187.05	-151.96
Operating Margin (%)	-474.75	-1,803.23	-1,078.08	-827.8	-1,663.27	-1,048.01	-547.48	-328.13	-396.96	-292.77	0.06	-58.85	-181.87	-193.29	-159.5
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	111.68	- -	- -	- -	- -
Pretax Margin (%)	-470.55	- -	-1,094.83	-935.49	-2,009.09	-1,046.23	-1,114.9	-342.05	-419.5	-343.32	0.06	-59.05	-188.4	-211.03	-170.66
Profit Margin (%)	-470.73	-1,799.35	-1,094.83	-935.49	-2,009.09	-1,046.23	-1,114.9	-342.05	-419.5	-343.32	0.06	-59.05	-188.4	-211.03	-170.66
Net Income to Common Margin (%)	-470.73	-1,799.35	-1,094.83	-935.49	-2,009.09	-1,046.23	-1,114.9	-342.05	-419.5	-343.32	0.06	-59.05	-188.4	-211.03	-170.66
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-108.5	-173.91	-353.83	- -	- -	-635.58	-388.09	-198.42	-578.92	-530.47	0.13	-56.95	-96.41	-189.48	- -

Credit (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	07/31/2010	07/31/2011	07/31/2012	07/31/2013	07/31/2014	07/31/2015	07/31/2016	07/31/2017	07/31/2018	07/31/2019	07/31/2020	07/31/2021	07/31/2022	07/31/2023	07/31/2024

Total Debt	- -	- -	1	1	- -	- -	- -	- -	1	- -	- -	- -	- -	1	3
ST Debt	- -	- -	1	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3
Total Debt/EBITDA	- -	- -	-0.11	-0.19	- -	- -	- -	- -	-0.07	- -	- -	-0.11	- -	-0.29	-0.99
Net Debt/EBITDA	0.35	0.23	-0.01	-0.19	0.01	0.18	0.76	0.29	0.05	0.07	-19.59	1.01	1.07	0.02	-0.87
Total Debt/EBIT	- -	- -	-0.11	-0.18	- -	- -	- -	- -	-0.07	- -	- -	-0.1	- -	-0.28	-0.94
Net Debt/EBIT	0.32	0.21	-0.01	-0.18	0.01	0.17	0.74	0.27	0.05	0.07	-959.75	0.93	1.01	0.02	-0.83
EBITDA to Interest Expense	- -	- -	-57.72	- -	- -	- -	-683.8	-1,146.4	-844.62	-891.33	39.2	-534.75	-526.17	-250.79	-19.25
EBITDA-CapEx/Interest Expense	- -	- -	-59.43	- -	- -	- -	-724.3	-1,191.6	-848.88	-893.5	27.6	-665	-539.67	-253.14	-19.25
EBIT to Interest Expense	- -	- -	-60.37	- -	- -	- -	-705.7	-1,201.6	-880.25	-931.5	0.8	-577.75	-561.67	-259.14	-20.2
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	90	81.72	18.35	-48.06	0.91	73.08	66.42	33.69	49.75	61.59	76.09	77.46	87.18	14.9	-350.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	375.37	- -
Long-Term Debt/Capital (%)	- -	- -	- -	335.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	78.96	3,469.41
Long-Term Debt/Total Assets (%)	- -	- -	- -	43.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	55.95	360.51
Total Debt/Equity (%)	- -	- -	117.6	-126.64	- -	- -	- -	- -	39.27	- -	- -	7.17	- -	375.37	-102.97
Total Debt/Capital (%)	- -	- -	54.04	475.38	- -	- -	- -	- -	28.2	- -	- -	6.69	- -	78.96	3,469.41
Total Debt/Total Assets (%)	- -	- -	21.58	60.86	- -	- -	- -	- -	19.53	- -	- -	5.55	- -	55.95	360.51
Net Debt to Equity	-40.64	-42.64	10.39	-123.41	-505.88	-55.43	-103.4	-127.13	-27.17	-33.45	-79.8	-64.54	-86.75	-27.21	-90.78
Net Debt/Capital (%)	-68.48	-74.35	9.41	527.16	124.64	-124.39	3,037.43	468.57	-37.3	-50.25	-394.96	-181.98	-654.63	-37.37	-984.85
EBITDA	-6	-8	-8	-6	-9	-7	-7	-6	-7	-5	- -	-2	-3	-4	-3
EBITDA-CapEx	-7	-8	-9	-7	-9	-8	-7	-6	-7	-5	- -	-3	-3	-4	-3
Operating Income (Loss)	-7	-8	-9	-7	-9	-8	-7	-6	-7	-6	- -	-2	-3	-4	-3

Liquidity (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	07/31/2010	07/31/2011	07/31/2012	07/31/2013	07/31/2014	07/31/2015	07/31/2016	07/31/2017	07/31/2018	07/31/2019	07/31/2020	07/31/2021	07/31/2022	07/31/2023	07/31/2024

Cash Ratio	3.76	1.92	0.24	0.01	0.05	1.52	2.05	0.65	0.66	0.54	2.54	2.46	5.9	2.06	0.48
Current Ratio	5.87	3	0.62	0.23	0.26	2.28	2.42	0.97	1.14	1.41	3.68	3.3	6.72	3.02	1.1
Quick Ratio	4.33	1.97	0.34	0.02	0.07	1.74	2.15	0.77	0.88	1.04	3.26	2.84	6.25	2.59	0.88
CFO/Avg Current Liab	-9.64	-8.07	-2.44	-1.35	-3.18	-4.49	-2.93	-1.8	-2.04	-2.96	0.59	-0.94	-3.13	-5.92	-4
Common Equity/Total Assets	90	81.72	18.35	-48.06	0.91	73.08	66.42	33.69	49.75	61.59	76.09	77.46	87.18	14.9	-350.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	375.37	- -
Long-Term Debt/Capital (%)	- -	- -	- -	335.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	78.96	3,469.41
Long-Term Debt/Total Assets (%)	- -	- -	- -	43.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	55.95	360.51
Total Debt/Equity (%)	- -	- -	117.6	-126.64	- -	- -	- -	- -	39.27	- -	- -	7.17	- -	375.37	-102.97
Total Debt/Capital (%)	- -	- -	54.04	475.38	- -	- -	- -	- -	28.2	- -	- -	6.69	- -	78.96	3,469.41
Total Debt/Total Assets (%)	- -	- -	21.58	60.86	- -	- -	- -	- -	19.53	- -	- -	5.55	- -	55.95	360.51
CFO/Total Liabilities	-921.7	-650.8	-153.52	-127.87	-343.43	-690.55	-196.57	-179.68	-300.39	-402.96	44.25	-120.31	-420.52	-211.08	-68.74
CFO/CapEx	-16.71	-25.1	-22.44	-16.9	-56.48	-56.66	-12.32	-20.19	-114.32	-230	11.53	-2.24	-29.85	-99.33	- -
Altman's Z-Score	75.93	-7.71	-43.42	-191.64	-272.47	-53.42	-9.17	-38.35	-78.72	-114.57	22.03	-22.33	-18.35	-103.37	-242.45

Working Capital (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	07/31/2010	07/31/2011	07/31/2012	07/31/2013	07/31/2014	07/31/2015	07/31/2016	07/31/2017	07/31/2018	07/31/2019	07/31/2020	07/31/2021	07/31/2022	07/31/2023	07/31/2024

Accounts Receivable Turnover	6.04	2.43	3.84	4.19	16.92	6.18	5.7	6.54	6.2	5.89	9.46	5.39	6.51	7.72	6.73
Days Sales Outstanding	60.43	150.44	95.07	87.02	21.57	59.08	64	55.82	58.84	61.95	38.57	67.71	56.04	47.25	54.2
Inventory Turnover	0.79	0.16	0.35	1.11	1.12	1.25	1.58	2.44	3.25	3.89	8	4.21	3.34	6.79	11.26
Days Inventory Outstanding	460.71	2,247.73	1,047.3	329.15	325.74	292	230.5	149.6	112.42	93.76	45.62	86.62	109.33	53.78	32.4
Accounts Payable Turnover	2.28	0.48	0.04	0.18	0.2	0.29	1.12	1.51	1.33	1.22	3.44	1.69	1.3	1.79	1.52
Accounts Payable Turnover Days	159.99	766.59	8,398.2	2,036.59	1,784.98	1,243.7	324.69	241.82	274.68	299.27	106	215.95	281.83	203.77	239.66
Cash Conversion Cycle	361.15	1,631.58	-7,255.83	-1,620.43	-1,437.67	-892.62	-30.19	-36.4	-103.42	-143.56	-21.8	-61.62	-116.46	-102.74	-153.06
Inventory to Cash Days	-400.28	-2,097.29	-952.23	-242.12	-304.17	-232.92	-166.51	-93.79	-53.57	-31.81	-7.05	-18.91	-53.29	-6.53	21.8
Inventories	1	1	1	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	07/31/2010	07/31/2011	07/31/2012	07/31/2013	07/31/2014	07/31/2015	07/31/2016	07/31/2017	07/31/2018	07/31/2019	07/31/2020	07/31/2021	07/31/2022	07/31/2023	07/31/2024

Market Capitalization	95	36	20	6	29	26	65	79	38	25	125	37	22	10	9
- Cash & Cash Equivalents	2	2	1	- -	- -	1	5	2	1	- -	4	2	3	1	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	1	- -	- -	- -	- -	1	- -	- -	- -	- -	1	3
Enterprise Value	93	35	20	7	29	25	60	77	38	25	121	34	19	9	12
Total Capital	5	4	2	- -	- -	2	5	1	2	1	5	4	4	1	- -
Total Debt/Capital (%)	- -	- -	54.04	475.38	- -	- -	- -	- -	28.2	- -	- -	6.69	- -	78.96	3,469.41
Total Debt / EV	- -	- -	0.05	0.18	- -	- -	- -	- -	0.01	- -	- -	0.01	- -	0.11	0.26
EV/Sales	64.95	74.65	24.98	8.39	53.29	34.09	46.76	42.18	21.39	12.85	17.45	8.78	10.17	5.03	5.87
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	615.69	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30,168.83	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	179.04	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	164.86	- -	- -	- -	- -
Diluted Market Cap	93	34	17	5	26	25	57	79	38	24	121	37	18	9	9
Diluted Enterprise Value	91	32	17	6	26	24	52	78	37	23	117	34	14	9	12
EV per Share	21.03	6.92	3.05	0.55	1	0.59	0.93	1.22	0.56	0.32	1.39	0.4	0.17	0.08	0.1
TTM Sales	1	- -	1	1	1	1	1	2	2	2	7	4	2	2	2
TTM EBITDA	-6	-8	-8	-6	-9	-7	-7	-6	-7	-5	- -	-2	-3	-4	-3
TTM Operating Income	-7	-8	-9	-7	-9	-8	-7	-6	-7	-6	- -	-2	-3	-4	-3
TTM Cash Flow to Firm	-6	- -	-5	-4	-6	-6	-5	-5	-4	-3	1	-1	-2	-3	-2
TTM Free Cash Flow to Firm	-5	- -	-5	-4	-6	-6	-5	-4	-4	-3	1	-1	-2	-3	-2

Multiples (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	07/31/2010	07/31/2011	07/31/2012	07/31/2013	07/31/2014	07/31/2015	07/31/2016	07/31/2017	07/31/2018	07/31/2019	07/31/2020	07/31/2021	07/31/2022	07/31/2023	07/31/2024

Price/Free Cash Flow	-17.9	-5.78	-3.2	-1.33	-4.12	-4.17	-12.52	-18.3	-9.8	-7.96	166.43	-56.68	-7.59	-2.92	-3.53
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30,168.83	- -	- -	- -	- -
Enterprise Value	93	35	20	7	29	25	60	77	38	25	121	34	19	9	12
Low Price	9.76	5.6	1.78	0.22	0.45	0.34	0.49	0.75	0.55	0.26	0.2	0.37	0.15	0.07	0.06
EV/Sales	64.95	74.65	24.98	8.39	53.29	34.09	46.76	42.18	21.39	12.85	17.45	8.78	10.17	5.03	5.87
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	615.69	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	29,389.89	- -	- -	- -	- -
Price/Earnings Average	-10.54	-8.13	-2.46	-1.35	-2.65	-3.97	-3.88	-10.2	-7.91	-5.21	12,821.66	-34.71	-6.6	-4.09	-3.33
Price/Earnings High	-19.11	-13.71	-5.31	-5.04	-3.94	-6.36	-6.13	-13.79	-11.75	-7.78	42,132.36	-69.54	-10.95	-6.63	-5.58
Price/Earnings Low	-6.23	-3.13	-1.13	-0.31	-1.04	-1.78	-1.93	-7.6	-4.97	-2.9	4,110.47	-13.81	-3.83	-1.97	-1.97
Price/Book Value	17.7	8.66	24.69	-5.71	1,729.11	10.98	13.03	61.14	29.89	20.96	25.88	10.99	5.69	34.96	-3.12
Price/Book Value Average	13.56	17.31	31.55	-12.09	1,979.32	13.37	12.66	49.2	46.6	30.23	11.29	24.16	7.39	59.78	-3.89
Price/Book Value High	24.6	29.19	68.23	-45.28	2,939.49	21.43	20	66.52	69.26	45.14	37.1	48.41	12.26	96.93	-6.52
Price/Book Value Low	8.03	6.66	14.46	-2.79	778.1	6.01	6.28	36.68	29.3	16.8	3.62	9.61	4.29	28.79	-2.3
Price/Tangible Book Value	27.11	15.91	-17.84	-2.34	-22.13	21.97	16.19	168.52	61.46	37.73	28.49	12.35	5.69	34.96	-3.12
Price/Tangible Book Value Average	20.78	31.8	-22.8	-4.95	-25.34	26.75	15.73	135.62	95.82	54.42	12.43	27.14	7.39	59.78	-3.89
Price/Tangible Book Value High	37.69	53.63	-49.31	-18.53	-37.63	42.88	24.85	183.35	142.41	81.26	40.85	54.39	12.26	96.93	-6.52
Price/Tangible Book Value Low	12.29	12.24	-10.45	-1.14	-9.96	12.02	7.81	101.11	60.25	30.24	3.99	10.8	4.29	28.79	-2.3
Price/Sales	64.71	73.2	21.05	5.95	46.56	34.09	44.53	43.35	21.28	12.41	17	9.32	9.57	5.04	4.55
Price/Sales Average	49.6	146.3	26.89	12.59	53.3	41.5	43.24	34.88	33.17	17.9	7.41	20.49	12.43	8.63	5.68
Price/Sales High	89.97	246.74	58.17	47.19	79.16	66.52	68.34	47.16	49.3	26.72	24.36	41.07	20.64	13.99	9.52
Price/Sales Low	29.35	56.31	12.33	2.91	20.95	18.65	21.47	26.01	20.86	9.95	2.38	8.15	7.22	4.15	3.36
Price/Cash Flow	-16.83	-5.55	-3.06	-1.25	-4.05	-4.1	-11.5	-17.4	-9.71	-7.92	175.72	-31.37	-7.34	-2.89	-3.53
Price/Cash Flow Average	-12.9	-11.08	-3.91	-2.65	-4.63	-4.99	-11.17	-14	-15.14	-11.43	76.66	-68.97	-9.53	-4.94	-4.4
Price/Cash Flow High	-23.39	-18.7	-8.45	-9.91	-6.88	-8	-17.65	-18.93	-22.5	-17.06	251.91	-138.19	-15.82	-8.01	-7.38
Price/Cash Flow Low	-7.63	-4.27	-1.79	-0.61	-1.82	-2.24	-5.54	-10.44	-9.52	-6.35	24.58	-27.44	-5.53	-2.38	-2.61
Price/Free Cash Flow Average	-13.72	-11.54	-4.09	-2.81	-4.72	-5.08	-12.15	-14.73	-15.27	-11.48	72.61	-124.59	-9.86	-4.99	-4.4
Price/Free Cash Flow High	-24.88	-19.47	-8.85	-10.53	-7.01	-8.14	-19.21	-19.91	-22.7	-17.14	238.59	-249.65	-16.36	-8.09	-7.38
Price/Free Cash Flow Low	-8.12	-4.44	-1.87	-0.65	-1.85	-2.28	-6.03	-10.98	-9.6	-6.38	23.28	-49.57	-5.72	-2.4	-2.61
EV/Sales Average	49.42	153.06	31.88	16.1	61.02	41.89	45.3	33.77	33.45	18.64	7.3	19.96	13.75	8.62	7
EV/Sales High	90.89	260.8	68.84	56.21	90.7	68.24	73.92	45.97	49.82	27.93	25.25	40.54	24.04	14.01	10.84
EV/Sales Low	28.62	56.53	14.67	4.87	23.89	17.83	20.46	24.95	20.96	10.26	1.96	7.61	7.21	4.13	4.69
EV/EBITDA Average	-11.18	-8.99	-3.09	-2.04	-3.77	-4.11	-8.54	-10.79	-8.78	-6.65	257.56	-36.64	-8.07	-4.61	-4.61
EV/EBITDA High	-20.56	-15.33	-6.68	-7.12	-5.61	-6.69	-13.93	-14.68	-13.08	-9.97	891.13	-74.43	-14.11	-7.49	-7.13
EV/EBITDA Low	-6.47	-3.32	-1.42	-0.62	-1.48	-1.75	-3.86	-7.97	-5.5	-3.66	69.26	-13.97	-4.23	-2.21	-3.08
EV/EBIT Average	-10.41	-8.49	-2.96	-1.94	-3.67	-4	-8.27	-10.29	-8.43	-6.37	12,620.43	-33.91	-7.56	-4.46	-4.39
EV/EBIT High	-19.15	-14.46	-6.39	-6.79	-5.45	-6.51	-13.5	-14.01	-12.55	-9.54	43,665.14	-68.89	-13.22	-7.25	-6.8
EV/EBIT Low	-6.03	-3.13	-1.36	-0.59	-1.44	-1.7	-3.74	-7.6	-5.28	-3.51	3,393.9	-12.93	-3.97	-2.14	-2.94
Last Price	21.52	7.28	3.04	0.45	1	0.63	1.01	1.25	0.56	0.32	1.43	0.42	0.2	0.08	0.08
High Price	29.92	24.54	8.4	3.57	1.7	1.22	1.55	1.36	1.3	0.7	2.05	1.85	0.43	0.24	0.17
Enterprise Value Average	71	71	26	13	34	31	58	62	59	36	50	78	25	16	14
Enterprise Value High	131	121	56	46	50	50	95	84	88	53	175	159	45	26	21
Enterprise Value Low	41	26	12	4	13	13	26	46	37	20	14	30	13	8	9

Shares Outstanding	4	5	7	13	29	42	65	63	68	77	87	87	111	112	112
Diluted Weighted Avg Shares	4	5	6	11	26	40	57	63	67	73	85	87	89	111	112
Basic Weighted Avg Shares	4	5	6	11	26	40	57	63	67	73	82	87	89	111	112
Revenue per Share	0.33	0.1	0.14	0.08	0.02	0.02	0.02	0.03	0.03	0.03	0.08	0.05	0.02	0.02	0.02
EBITDA per Share	-1.47	-1.69	-1.49	-0.6	-0.35	-0.19	-0.12	-0.09	-0.1	-0.07	- -	-0.02	-0.04	-0.03	-0.03
Operating Income per Share	-1.58	-1.79	-1.56	-0.63	-0.36	-0.19	-0.12	-0.09	-0.1	-0.08	- -	-0.03	-0.04	-0.03	-0.03
Basic EPS, GAAP	-1.57	-1.79	-1.58	-0.71	-0.43	-0.19	-0.25	-0.1	-0.11	-0.09	- -	-0.03	-0.04	-0.04	-0.03
Basic EPS from Cont Ops	-1.57	-1.79	-1.58	-0.71	-0.43	-0.19	-0.25	-0.1	-0.11	-0.09	- -	-0.03	-0.04	-0.04	-0.03
Diluted EPS, GAAP	-1.57	-1.79	-1.58	-0.71	-0.43	-0.19	-0.25	-0.1	-0.11	-0.09	- -	-0.03	-0.04	-0.04	-0.03
Diluted EPS from Cont Ops	-1.57	-1.79	-1.58	-0.71	-0.43	-0.19	-0.25	-0.1	-0.11	-0.09	- -	-0.03	-0.04	-0.04	-0.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.28	-1.31	-0.99	-0.36	-0.25	-0.15	-0.09	-0.07	-0.06	-0.04	0.01	-0.01	-0.03	-0.03	-0.02
Free Cash Flow per Basic Share	-1.36	-1.36	-1.04	-0.38	-0.25	-0.16	-0.09	-0.08	-0.06	-0.04	0.01	-0.02	-0.03	-0.03	-0.02
Cash & Equivalents per Share	0.49	0.36	0.13	- -	- -	0.03	0.08	0.03	0.01	0.01	0.04	0.03	0.03	0.01	- -
Book Value per Share	1.22	0.84	0.12	-0.08	- -	0.06	0.08	0.02	0.02	0.02	0.06	0.04	0.04	- -	-0.03
Tangible Book Value per Share	0.79	0.46	-0.17	-0.19	-0.05	0.03	0.06	0.01	0.01	0.01	0.05	0.03	0.04	- -	-0.03

PURE Bioscience, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)